Additionally, the biosensor may be employed in screening endeavours to identify small molecule drugs that disrupt Merlin’s intramolecular interactions and activate its tumour suppressor function, a strategy successfully implemented in our previous work [54,55,56,57]. The gene discussed is NF2; the disease is neoplasm.